Literature DB >> 19473253

Mycoplasma biofilms ex vivo and in vivo.

Warren L Simmons1, Kevin Dybvig.   

Abstract

Biofilms are communities of microorganisms that are encased in polymeric matrixes and grow attached to biotic or abiotic surfaces. Despite their enhanced ability to resist antimicrobials and components of the immune system in vitro, few studies have addressed the interactions of biofilms with the host at the organ level. Although mycoplasmas have been shown to form biofilms on glass and plastic surfaces, it has not been determined whether they form biofilms on the tracheal epithelium. We developed a tracheal organ-mounting system that allowed the entire surface of the tracheal lumen to be scanned using fluorescence microscopy. We observed the biofilms formed by the murine respiratory pathogen Mycoplasma pulmonis on the epithelium of trachea in tracheal organ culture and in experimentally infected mice and found similar structure and biological characteristics as biofilms formed in vitro. This tracheal organ-mounting system can be used to study interactions between biofilms formed by respiratory pathogens and the host epithelium and to identify the factors that contribute to biofilm formation in vivo.

Entities:  

Mesh:

Year:  2009        PMID: 19473253      PMCID: PMC2703428          DOI: 10.1111/j.1574-6968.2009.01592.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  7 in total

1.  Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidin.

Authors:  Warren L Simmons; Kevin Dybvig
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

2.  Mechanism of antigenic variation in Mycoplasma pulmonis: interwoven, site-specific DNA inversions.

Authors:  B Bhugra; L L Voelker; N Zou; H Yu; K Dybvig
Journal:  Mol Microbiol       Date:  1995-11       Impact factor: 3.501

3.  Variations in the surface proteins and restriction enzyme systems of Mycoplasma pulmonis in the respiratory tract of infected rats.

Authors:  J Gumulak-Smith; A Teachman; A H Tu; J W Simecka; J R Lindsey; K Dybvig
Journal:  Mol Microbiol       Date:  2001-05       Impact factor: 3.501

4.  A stochastic mechanism for biofilm formation by Mycoplasma pulmonis.

Authors:  Warren L Simmons; Jeffrey R Bolland; James M Daubenspeck; Kevin Dybvig
Journal:  J Bacteriol       Date:  2006-12-01       Impact factor: 3.490

5.  Avoidance of the host immune system through phase variation in Mycoplasma pulmonis.

Authors:  Amy M Denison; Brenda Clapper; Kevin Dybvig
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

6.  Resistance of Mycoplasma pulmonis to complement lysis is dependent on the number of Vsa tandem repeats: shield hypothesis.

Authors:  Warren L Simmons; Amy M Denison; Kevin Dybvig
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

7.  The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement killing, hemadsorption, and adherence to polystyrene.

Authors:  Warren L Simmons; Kevin Dybvig
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

  7 in total
  12 in total

1.  Mycoplasma pulmonis Vsa proteins and polysaccharide modulate adherence to pulmonary epithelial cells.

Authors:  Jeffrey R Bolland; Kevin Dybvig
Journal:  FEMS Microbiol Lett       Date:  2012-04-10       Impact factor: 2.742

Review 2.  Options and Limitations in Clinical Investigation of Bacterial Biofilms.

Authors:  Maria Magana; Christina Sereti; Anastasios Ioannidis; Courtney A Mitchell; Anthony R Ball; Emmanouil Magiorkinis; Stylianos Chatzipanagiotou; Michael R Hamblin; Maria Hadjifrangiskou; George P Tegos
Journal:  Clin Microbiol Rev       Date:  2018-04-04       Impact factor: 26.132

3.  Type 1 and type 2 strains of Mycoplasma pneumoniae form different biofilms.

Authors:  Warren L Simmons; James M Daubenspeck; John D Osborne; Mitchell F Balish; Ken B Waites; Kevin Dybvig
Journal:  Microbiology       Date:  2013-02-14       Impact factor: 2.777

4.  The Vsa shield of Mycoplasma pulmonis is antiphagocytic.

Authors:  Brandon M Shaw; Warren L Simmons; Kevin Dybvig
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

5.  Identification of exopolysaccharide-deficient mutants of Mycoplasma pulmonis.

Authors:  James M Daubenspeck; Jeffrey R Bolland; Wenyi Luo; Warren L Simmons; Kevin Dybvig
Journal:  Mol Microbiol       Date:  2009-05-07       Impact factor: 3.501

6.  Role of biofilm formation in Ureaplasma antibiotic susceptibility and development of bronchopulmonary dysplasia in preterm neonates.

Authors:  Katherine Pandelidis; Amanda McCarthy; Kirsty L Chesko; Rose M Viscardi
Journal:  Pediatr Infect Dis J       Date:  2013-04       Impact factor: 2.129

Review 7.  From in vitro to in vivo Models of Bacterial Biofilm-Related Infections.

Authors:  David Lebeaux; Ashwini Chauhan; Olaya Rendueles; Christophe Beloin
Journal:  Pathogens       Date:  2013-05-13

8.  Visualisation and biovolume quantification in the characterisation of biofilm formation in Mycoplasma fermentans.

Authors:  Ammar A Awadh; Alison F Kelly; Gary Forster-Wilkins; David Wertheim; Richard Giddens; Simon W Gould; Mark D Fielder
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

9.  The Role of Lipoproteins in Mycoplasma-Mediated Immunomodulation.

Authors:  Alexei Christodoulides; Neha Gupta; Vahe Yacoubian; Neil Maithel; Jordan Parker; Theodoros Kelesidis
Journal:  Front Microbiol       Date:  2018-07-31       Impact factor: 6.064

10.  Extracellular DNA release from the genome-reduced pathogen Mycoplasma hyopneumoniae is essential for biofilm formation on abiotic surfaces.

Authors:  Benjamin B A Raymond; Cheryl Jenkins; Lynne Turnbull; Cynthia B Whitchurch; Steven P Djordjevic
Journal:  Sci Rep       Date:  2018-07-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.